Valuation: Hansoh Pharmaceutical Group Company Limited

Capitalization 219B 245B 31.44B 26.89B 24.96B 23.41B 43.42B 2,880B 46.5B 286B 113B 1,361B 118B 116B 4,972B P/E ratio 2025 *
42x
P/E ratio 2026 * 39.7x
Enterprise value 193B 216B 27.67B 23.66B 21.96B 20.6B 38.22B 2,535B 40.92B 252B 99.75B 1,198B 104B 102B 4,376B EV / Sales 2025 *
13.1x
EV / Sales 2026 * 11.8x
Free-Float
18.75%
Yield 2025 *
0.86%
Yield 2026 * 0.89%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.49%
1 week-6.15%
Current month+11.70%
1 month+4.95%
3 months+12.26%
6 months+12.26%
Current year+11.70%
More quotes
1 week 39.26
Extreme 39.26
44.22
1 month 35.54
Extreme 35.54
44.22
Current year 35.7
Extreme 35.7
44.22
1 year 17.06
Extreme 17.06
44.22
3 years 9.41
Extreme 9.41
44.22
5 years 9.41
Extreme 9.41
45.95
10 years 9.41
Extreme 9.41
46.7
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 02/12/2015
Corporate Secretary 37 26/12/2025
Corporate Secretary 58 01/08/2018
Director TitleAgeSince
Director/Board Member 83 31/05/2019
Director/Board Member 72 31/05/2019
Director/Board Member 69 31/05/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.59%-6.15%+134.03%+135.67% 31.44B
+3.58%+0.49%+45.28%+211.65% 966B
-0.09%-0.25%+47.15%+29.20% 525B
+0.99%-2.59%+25.22%+44.49% 382B
-0.38%+1.11%+29.15%+17.13% 371B
-1.35%-4.78%+23.57%+19.09% 278B
+0.07%+0.62%+28.14%+35.35% 276B
-4.02%-2.47%-32.19%-22.60% 260B
+1.52%+0.09%+15.45%+1.06% 276B
+3.81%+4.45%+25.03%+30.53% 185B
Average -0.10%-1.30%+34.08%+50.16% 355.06B
Weighted average by Cap. -0.33%-0.73%+30.42%+73.92%
See all sector performances

Financials

2025 *2026 *
Net sales 14.69B 16.45B 2.11B 1.8B 1.67B 1.57B 2.91B 193B 3.12B 19.22B 7.6B 91.33B 7.91B 7.75B 334B 15.96B 17.87B 2.29B 1.96B 1.82B 1.71B 3.17B 210B 3.39B 20.88B 8.26B 99.23B 8.6B 8.42B 362B
Net income 5.05B 5.66B 726M 620M 576M 540M 1B 66.46B 1.07B 6.61B 2.62B 31.41B 2.72B 2.67B 115B 5.43B 6.08B 780M 667M 619M 581M 1.08B 71.47B 1.15B 7.11B 2.81B 33.78B 2.93B 2.87B 123B
Net Debt -26.26B -29.4B -3.77B -3.22B -2.99B -2.81B -5.21B -345B -5.58B -34.35B -13.59B -163B -14.14B -13.85B -596B -30.26B -33.88B -4.35B -3.71B -3.45B -3.23B -6B -398B -6.42B -39.58B -15.66B -188B -16.29B -15.96B -687B
More financial data * Estimated data
Logo Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.
Employees
9,313
More about the company
Date Price Change Volume
22/01/26 40.24 $ -0.64% 4,032,194
21/01/26 40.50 $ +0.55% 4,908,334
20/01/26 40.28 $ -2.42% 6,185,523
19/01/26 41.28 $ -4.00% 6,031,453
16/01/26 43.00 $ -0.28% 3,706,567

Delayed Quote Hong Kong S.E., January 22, 2026 at 03:37 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
36.17CNY
Average target price
40.67CNY
Spread / Average Target
+12.43%
Consensus

Quarterly revenue - Rate of surprise